MedTrace Logo

In Vivo Smart Biopsy Device Protocol In Radiology

NCT03914911 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2020-01-31

No results posted yet for this study

Summary

This study is designed to demonstrate the feasibility of use of the Smart Biopsy Device in real clinical settings.

Conditions

Interventions

DEVICE

Smart Biopsy Device

The radiologist will perform a routine ultrasonic guided biopsy procedure using the smart biopsy system, with the device readings not visible (i.e. the radiologist will be blinded to device readings)

Sponsors & Collaborators

  • Dune Medical Devices

    lead INDUSTRY

Principal Investigators

  • Noemi Weisenberg · Meir Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2020-02-28
Completion
2020-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03914911 on ClinicalTrials.gov